Search - tctmd.com

Displaying 1 - 20 of 568

Sort: Relevancy | Date

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

Caitlin E. Cox

March 30, 2026

Presentation ACC 2026

Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results From the Phase 2, Randomized, Placebo-Controlled CADENCE Study

Presenter: Mardi Gomberg-Maitland

March 29, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

Presentation THT Abstracts 2026

Impact of Pulmonary Hypertension Subtypes on Clinical Outcomes and Resource Utilization in Heart Failure

Presenter: Bryce Allen

March 03, 2026

Presentation THT 2026

Pulmonary Artery Denervation (PADN) Treatment in Patients with Pulmonary Hypertension Due to Left Heart Disease: Initial Results of the PreVail-PH2 Early Feasibility Study

Presenter: Ryan J. Tedford

March 03, 2026

Presentation THT Abstracts 2026

Impact of Pulmonary Hypertension Subtypes on Clinical Outcomes and Resource Utilization in Heart Failure

Presenter: Aarjuv Majmundar

March 02, 2026

Presentation THT 2026

Disentangling The Central, Peripheral And Hematological Mechanisms Of Benefit Of Sotatercept On Exercise Performance In Pulmonary Arterial Hypertension

Presenter: Yogesh Reddy

March 02, 2026

Presentation THT 2026

3-year changes in pulmonary artery pressures and pulmonary hypertension classification in remotely monitored heart failure patients

Presenter: Ryan J. Tedford

March 02, 2026

News Features

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Michael O'Riordan

February 24, 2026

News Conference News STS 2026

Hearts Donated After Circulatory vs Brain Death Tied to More Graft Dysfunction but Similar Survival

Yael L. Maxwell

February 06, 2026

News Daily News

PULSAR: Globe Pulsed-Field Ablation System Performs Well in Paroxysmal AF

Todd Neale

January 27, 2026

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Caitlin E. Cox

December 31, 2025

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Daily News

ANOCA May Not Be as Risky as Feared: Danish Data

Caitlin E. Cox

December 15, 2025

News Daily News

Mortality and Other Adverse Events After TAVI Higher in Frailer Patients

Yael L. Maxwell

November 25, 2025

News Conference News AHA 2025

DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation

Todd Neale

November 12, 2025

Presentation TCT 2025

Novel Structural Therapies for Pulmonary Hypertension: Balancing Safety, Functional Improvements, and Clinical Efficacy

Presenter: Daniel Burkhoff

October 28, 2025

Presentation TCT 2025

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

Presenter: Jorrian Abadeer

October 28, 2025

Presentation TCT 2025

TCT 1055: Innovative Mechanical Thrombectomy Approach: In Vivo Comparison of the Vicora Vibrato Device and Standard of Care in a Porcine Model

Presenter: Erin Marie Garcia

October 28, 2025

Presentation TCT 2025

TCT 1053: Right Ventricular Myocardial Performance Score as Potential Predictor of Response to Catheter Directed Thrombolytics for Acute Pulmonary Embolism

Presenter: Rohan Mundkur

October 28, 2025

Advertisement

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results From the Phase 2, Randomized, Placebo-Controlled CADENCE Study

What’s Going to Be Hot at ACC 2026

Impact of Pulmonary Hypertension Subtypes on Clinical Outcomes and Resource Utilization in Heart Failure

Pulmonary Artery Denervation (PADN) Treatment in Patients with Pulmonary Hypertension Due to Left Heart Disease: Initial Results of the PreVail-PH2 Early Feasibility Study

Impact of Pulmonary Hypertension Subtypes on Clinical Outcomes and Resource Utilization in Heart Failure

Disentangling The Central, Peripheral And Hematological Mechanisms Of Benefit Of Sotatercept On Exercise Performance In Pulmonary Arterial Hypertension

3-year changes in pulmonary artery pressures and pulmonary hypertension classification in remotely monitored heart failure patients

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Hearts Donated After Circulatory vs Brain Death Tied to More Graft Dysfunction but Similar Survival

PULSAR: Globe Pulsed-Field Ablation System Performs Well in Paroxysmal AF

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

ANOCA May Not Be as Risky as Feared: Danish Data

Mortality and Other Adverse Events After TAVI Higher in Frailer Patients

DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation

Novel Structural Therapies for Pulmonary Hypertension: Balancing Safety, Functional Improvements, and Clinical Efficacy

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

TCT 1055: Innovative Mechanical Thrombectomy Approach: In Vivo Comparison of the Vicora Vibrato Device and Standard of Care in a Porcine Model

TCT 1053: Right Ventricular Myocardial Performance Score as Potential Predictor of Response to Catheter Directed Thrombolytics for Acute Pulmonary Embolism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content